2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome

The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be r...

Full description

Saved in:
Bibliographic Details
Main Authors: Jack Wei Chieh Tan, Derek P Chew, David Brieger, John Eikelboom, Gilles Montalescot, Junya Ako, Byeong-Keuk Kim, David KL Quek, Sarah J Aitken, Clara K Chow, Sok Chour, Hung Fat Tse, Upendra Kaul, Isman Firdaus, Takashi Kubo, Boon Wah Liew, Tze Tec Chong, Kenny YK Sin, Hung-I Yeh, Wacin Buddhari, Narathip Chunhamaneewat, Faisal Hasan, Keith AA Fox, Quang Ngoc Nguyen, Sidney TH Lo
Format: Article
Language:English
Published: Radcliffe Medical Media 2021-06-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2020.45
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846122471574470656
author Jack Wei Chieh Tan
Derek P Chew
David Brieger
John Eikelboom
Gilles Montalescot
Junya Ako
Byeong-Keuk Kim
David KL Quek
Sarah J Aitken
Clara K Chow
Sok Chour
Hung Fat Tse
Upendra Kaul
Isman Firdaus
Takashi Kubo
Boon Wah Liew
Tze Tec Chong
Kenny YK Sin
Hung-I Yeh
Wacin Buddhari
Narathip Chunhamaneewat
Faisal Hasan
Keith AA Fox
Quang Ngoc Nguyen
Sidney TH Lo
author_facet Jack Wei Chieh Tan
Derek P Chew
David Brieger
John Eikelboom
Gilles Montalescot
Junya Ako
Byeong-Keuk Kim
David KL Quek
Sarah J Aitken
Clara K Chow
Sok Chour
Hung Fat Tse
Upendra Kaul
Isman Firdaus
Takashi Kubo
Boon Wah Liew
Tze Tec Chong
Kenny YK Sin
Hung-I Yeh
Wacin Buddhari
Narathip Chunhamaneewat
Faisal Hasan
Keith AA Fox
Quang Ngoc Nguyen
Sidney TH Lo
author_sort Jack Wei Chieh Tan
collection DOAJ
description The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.
format Article
id doaj-art-6e65974c60be45ae9133bd9a4386d9a8
institution Kabale University
issn 1758-3756
1758-3764
language English
publishDate 2021-06-01
publisher Radcliffe Medical Media
record_format Article
series European Cardiology Review
spelling doaj-art-6e65974c60be45ae9133bd9a4386d9a82024-12-14T16:02:49ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642021-06-011610.15420/ecr.2020.452020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary SyndromeJack Wei Chieh Tan0Derek P Chew1David Brieger2John Eikelboom3Gilles Montalescot4Junya Ako5Byeong-Keuk Kim6David KL Quek7Sarah J Aitken8Clara K Chow9Sok Chour10Hung Fat Tse11Upendra Kaul12Isman Firdaus13Takashi Kubo14Boon Wah Liew15Tze Tec Chong16Kenny YK Sin17Hung-I Yeh18Wacin Buddhari19Narathip Chunhamaneewat20Faisal Hasan21Keith AA Fox22Quang Ngoc Nguyen23Sidney TH Lo24National Heart Centre, Singapore; Sengkang General Hospital, SingaporeCollege of Medicine and Public Health, Flinders University, Adelaide, AustraliaConcord Repatriation General Hospital, University of Sydney, Sydney, AustraliaMcMaster University, Ontario, CanadaSorbonne University, Paris, France; ACTION Study Group, France; Pitié-Salpêtrière University Hospital (AP-HP), Paris, FranceKitasato University and Hospital, Kanagawa, JapanYonsei University College of Medicine, South KoreaPantai Hospital Kuala Lumpur, Kuala Lumpur, MalaysiaUniversity of Sydney, Sydney, AustraliaWestmead Applied Research Centre, University of Sydney, Sydney, Australia; Westmead Hospital, Sydney, AustraliaCalmette Hospital, Phnom Penh, CambodiaQueen Mary Hospital, University of Hong Kong, Hong Kong, ChinaBatra Hospital and Medical Research Center, New Delhi, IndiaFaculty of Medicine, University of Indonesia, Jakarta, IndonesiaWakayama Medical University, Wakayama, JapanChangi General Hospital, SingaporeSingapore General Hospital, SingaporeNational Heart Centre, SingaporeMacKay Memorial Hospital, MacKay Medical College, Taipei, TaiwanKing Chulalongkorn Memorial Hospital, Bangkok, ThailandSiriraj Hospital, Mahidol University, Bangkok, ThailandHeart & Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesUniversity of Edinburgh, Edinburgh, UKHanoi Medical University, Vietnam National Heart Institute, Hanoi, VietnamLiverpool Hospital, Sydney, AustraliaThe unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.https://www.ecrjournal.com/articleindex/ecr.2020.45
spellingShingle Jack Wei Chieh Tan
Derek P Chew
David Brieger
John Eikelboom
Gilles Montalescot
Junya Ako
Byeong-Keuk Kim
David KL Quek
Sarah J Aitken
Clara K Chow
Sok Chour
Hung Fat Tse
Upendra Kaul
Isman Firdaus
Takashi Kubo
Boon Wah Liew
Tze Tec Chong
Kenny YK Sin
Hung-I Yeh
Wacin Buddhari
Narathip Chunhamaneewat
Faisal Hasan
Keith AA Fox
Quang Ngoc Nguyen
Sidney TH Lo
2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
European Cardiology Review
title 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
title_full 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
title_fullStr 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
title_full_unstemmed 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
title_short 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
title_sort 2020 asian pacific society of cardiology consensus recommendations on antithrombotic management for high risk chronic coronary syndrome
url https://www.ecrjournal.com/articleindex/ecr.2020.45
work_keys_str_mv AT jackweichiehtan 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT derekpchew 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT davidbrieger 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT johneikelboom 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT gillesmontalescot 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT junyaako 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT byeongkeukkim 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT davidklquek 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT sarahjaitken 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT clarakchow 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT sokchour 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT hungfattse 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT upendrakaul 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT ismanfirdaus 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT takashikubo 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT boonwahliew 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT tzetecchong 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT kennyyksin 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT hungiyeh 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT wacinbuddhari 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT narathipchunhamaneewat 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT faisalhasan 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT keithaafox 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT quangngocnguyen 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome
AT sidneythlo 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome